These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 215911)

  • 1. The metabolic defect in Tangier Disease.
    Herbert PN
    N Engl J Med; 1979 Feb; 300(8):432-3. PubMed ID: 215911
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of high-density lipoprotein apolipoproteins in Tangier disease.
    Schaefer EJ; Blum CB; Levy RI; Jenkins LL; Alaupovic P; Foster DM; Brewer HB
    N Engl J Med; 1978 Oct; 299(17):905-10. PubMed ID: 211412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoprotein A-I synthesis in normal intestinal mucosa and in Tangier disease.
    Glickman RM; Green PH; Lees RS; Tall A
    N Engl J Med; 1978 Dec; 299(26):1424-7. PubMed ID: 213720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tangier disease: one explanation of lipid storage.
    Herbert PN; Forte T; Heinen RJ; Fredrickson DS
    N Engl J Med; 1978 Sep; 299(10):519-21. PubMed ID: 210378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of high density lipoproteins in patients heterozygous for Tangier disease.
    Assmann G; Simantke O; Schaefer HE; Smootz E
    J Clin Invest; 1977 Nov; 60(5):1025-35. PubMed ID: 198431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial high-density lipoprotein deficiency (Tangier disease): the third Italian case.
    Bracco G; Dotti G; Levis F; David E; Saracco G; Rizzetto M; Verme G
    J Inherit Metab Dis; 1988; 11 Suppl 2():155-7. PubMed ID: 3141697
    [No Abstract]   [Full Text] [Related]  

  • 7. Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).
    Schaefer EJ; Kay LL; Zech LA; Brewer HB
    J Clin Invest; 1982 Nov; 70(5):934-45. PubMed ID: 7130397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease).
    Schaefer EJ; Zech LA; Schwartz DE; Brewer HB
    Ann Intern Med; 1980 Aug; 93(2):261-6. PubMed ID: 7406376
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of high density lipoprotein with adipocytes in a new patient with Tangier disease.
    Frohlich J; Fong B; Julien P; Despres JP; Angel A; Hayden M; McLeod R; Chow C; Davison RH; Pritchard H
    Clin Invest Med; 1987 Sep; 10(5):377-82. PubMed ID: 3677505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of Tangier disease].
    Kosaka A; Hayashi H
    Rinsho Byori; 1988 Aug; 36(8):988-91. PubMed ID: 3149352
    [No Abstract]   [Full Text] [Related]  

  • 11. Charge-shift electrophoresis of apolipoproteins from normal humans and patients with Tangier disease.
    Utermann G; Beisiegel U
    FEBS Lett; 1979 Jan; 97(2):245-8. PubMed ID: 216585
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormal concentration and anomalous distribution of apolipoprotein A-I in Tangier disease.
    Henderson LO; Herbert PN; Fredrickson DS; Heinen RJ; Easterling JC
    Metabolism; 1978 Feb; 27(2):165-74. PubMed ID: 622047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of lipoprotein families in a variant of human plasma apolipoprotein A deficiency.
    Gustafson A; McConathy WJ; Alaupovic P; Curry MD; Persson B
    Scand J Clin Lab Invest; 1979 Jun; 39(4):377-87. PubMed ID: 230573
    [No Abstract]   [Full Text] [Related]  

  • 14. Bile lipid composition and haemostatic variables in a case of high density lipoprotein deficiency (Tangier disease).
    Vergani CG; Plancher AC; Zuin M; Cattaneo M; Tramaloni C; Maccari S; Roma P; Catapano AL
    Eur J Clin Invest; 1984 Feb; 14(1):49-54. PubMed ID: 6421598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal apoprotein A-I isoprotein composition in patients with Tangier disease.
    Zannis VI; Lees AM; Lees RS; Breslow JL
    J Biol Chem; 1982 May; 257(9):4978-86. PubMed ID: 7068673
    [No Abstract]   [Full Text] [Related]  

  • 16. High-density lipoproteins and the risk of atherosclerosis.
    Lees RS; Lees AM
    N Engl J Med; 1982 Jun; 306(25):1546-8. PubMed ID: 7078610
    [No Abstract]   [Full Text] [Related]  

  • 17. Apoprotein A metabolism in Tangier disease.
    Assmann G; Capurso A; Smootz E; Wellner U
    Atherosclerosis; 1978 Aug; 30(4):321-32. PubMed ID: 213084
    [No Abstract]   [Full Text] [Related]  

  • 18. Bile lipids, platelet aggregability and pro-ApoAI processing in 2 cases of Tangier disease.
    Catapano AL; Giudici G; Roma P; Vergani CG
    Monogr Atheroscler; 1986; 14():154-8. PubMed ID: 3736556
    [No Abstract]   [Full Text] [Related]  

  • 19. Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.
    Schmitz G; Assmann G; Rall SC; Mahley RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6081-5. PubMed ID: 6412234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of high density lipoproteins in lecithin:cholesterol acyltransferase activity: perspectives from Tangier disease.
    Assmann G; Schmitz G; Heckers H
    Scand J Clin Lab Invest Suppl; 1978; 150():98-102. PubMed ID: 218282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.